Kelly Malcom
Lead Research Communicator

Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]
Kelly Malcom photo
Close up of ecoli bacteria
Health Lab
Bad Bacteria Make Their Own Food to Colonize the Gut
How E coli. and other illness-causing bugs get past the microbiome’s defenses.
Health Lab
COVID-19 Through the Lens of Basic Science
Watch four Michigan Medicine experts discuss the role of fundamental science in ending the COVID-19 pandemic.
 drawing on lined paper of heart in blue ink
Health Lab
Weakened Hearts Linked to a Build-Up of Phosphate
A computer simulation reveals the metabolic dysfunction behind heart failure.
 blood pressure dial with green yellow and red with mouse
Health Lab
High Blood Pressure Linked to Baroreflex in Rats
Animal model observation may reveal new cause of hypertension.
 yellow sand clock on dark blue background
Health Lab
High Throughput Screening Identifies Molecules That Reduce Cellular Stress
While there is no actual fountain of youth, a new study shows a high throughput technique could help researchers find drugs that improve health and lengthen lifespan.
Health Lab
Questions and Answers About COVID-19 Vaccine Clinical Trials
Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.
 Mature forest on fire
Health Lab
Wildfires: How to protect your lung health in poor air quality
With raging wildfires affecting air quality, protecting your lung health is key.
 people drawn in masks
Health Lab
Should We Worry About COVID-19 Reinfection?
U-M expert discusses whether repeat cases of COVID-19 is bad news for vaccines.
News Release
U-M partners with NIH ACTIV Initiative for clinical trial of blood clotting treatments for COVID-19
The University of Michigan is one of several academic medical centers partnering with the National Institutes of Health on three adaptive clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.
 HIV attacking cells in purple pink and red
Health Lab
Antibiotic Molecule Enables Immune System to Kill HIV Infected Cells
New research shows that targeting a protein called Nef with a molecule called concanamycin A allowed the immune system to essentially cure HIV in T cells.
 microscope drawn in blue ink on notepad paper
Health Lab
Immune Cell CXCR3 Receptor Behind Lethal Brain Damage Following Treatment for Fungal Infection
Finding could improve outcomes for treatment of infections in people living with HIV.
News Release
U-M to conduct clinical trial to test AstraZeneca COVID-19 vaccine
Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2).
 drawing of a pink brain on a dark pink background
Health Lab
Investigational New Therapy Prevents Onset of Dravet Syndrome Symptoms in Mice
Development is first step to helping children with the rare epilepsy syndrome.
Health Lab
Vaccine Q&A: From Flu to COVID-19, Everything You Need to Know
From flu shots to a vaccine for COVID-19, from herd immunity to vaccine safety, Dr. Pam Rockwell explains why vaccines are so important, especially during a pandemic.
 image of x-ray of lungs, two hands holding it
Health Lab
Oxygen Therapy Harms Lung Microbiome in Mice
New research in mice suggests that understanding the role of the lung microbiome may be pivotal to reducing infection brought on by oxygen treatment for hypoxemia.
  • …
  • 11
  • 12
  • 13
    •